- Home
- FSBW vs PRQR Comparison
FSBW vs PRQR Comparison
Compare FSBW & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSBW
- PRQR
- Stock Information
- Founded
- FSBW 1936
- PRQR 2012
- Country
- FSBW United States
- PRQR Netherlands
- Employees
- FSBW N/A
- PRQR N/A
- Industry
- FSBW Banks
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- FSBW Finance
- PRQR Health Care
- Exchange
- FSBW Nasdaq
- PRQR Nasdaq
- Market Cap
- FSBW 318.4M
- PRQR 309.5M
- IPO Year
- FSBW 2012
- PRQR 2014
- Fundamental
- Price
- FSBW $36.76
- PRQR $1.68
- Analyst Decision
- FSBW Hold
- PRQR Strong Buy
- Analyst Count
- FSBW 1
- PRQR 6
- Target Price
- FSBW $44.00
- PRQR $8.50
- AVG Volume (30 Days)
- FSBW 12.6K
- PRQR 406.6K
- Earning Date
- FSBW 04-23-2025
- PRQR 03-13-2025
- Dividend Yield
- FSBW 2.94%
- PRQR N/A
- EPS Growth
- FSBW N/A
- PRQR N/A
- EPS
- FSBW 4.36
- PRQR N/A
- Revenue
- FSBW $139,150,000.00
- PRQR $20,235,014.00
- Revenue This Year
- FSBW $9.22
- PRQR $39.44
- Revenue Next Year
- FSBW $6.31
- PRQR N/A
- P/E Ratio
- FSBW $8.43
- PRQR N/A
- Revenue Growth
- FSBW 0.09
- PRQR 105.20
- 52 Week Low
- FSBW $30.64
- PRQR $1.61
- 52 Week High
- FSBW $49.15
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- FSBW 39.72
- PRQR 27.75
- Support Level
- FSBW $35.46
- PRQR $1.78
- Resistance Level
- FSBW $38.01
- PRQR $1.87
- Average True Range (ATR)
- FSBW 0.94
- PRQR 0.15
- MACD
- FSBW -0.12
- PRQR -0.05
- Stochastic Oscillator
- FSBW 30.66
- PRQR 0.00
About FSBW FS Bancorp Inc.
FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking, and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.